To the Editor,

I have read the article entitled "Heart rate recovery, cardiac rehabilitation, and erectile dysfunction in males with ischemic heart disease" by Kałka et al. ([@ref1]) with great interest, which was recently published in Anatolian Journal of Cardiology 2016; 16: 256-63. The investigators reported that in patients with ischemic heart disease (IHD) and erectile dysfunction (ED) subjected to cardiac rehabilitation, enhancement of autonomic balance assessed using heart rate recovery (HRR) plays a significant role in the mechanism of improvement in erection quality ([@ref1]). Authors have reported that there was no significant difference with regard to beta-blocker therapy ([@ref1]).

Beta-blockers are one of the most commonly used and cornerstone therapy in the treatment of ischemic heart disease ([@ref2]). Nebivolol is a third-generation beta-blocker, and has a vasodilating effect that is attributed to the generation of endothelial nitric oxide, in addition to β1-adrenoceptor selectivity ([@ref3]).

It is well known that beta-blocker therapy effect might be different with regard to ED depending on sort of it in patients with IHD ([@ref4]). Aldemir et al. ([@ref4]) have reported that although ED in males undergoing CABG surgery decreases when metoprolol is used, nebivolol had a protective effect on the sexual activity of men undergoing coronary artery bypass surgery with cardiopulmonary bypass. In addition, Brixius et al. ([@ref5]) have reported beneficial effects of nebivolol on the erectile function in hypertensive men.

I would like to emphasize one important point to clarify in this article. Kind of beta-blocker therapy is very important to evaluate ED in patients with IHD ([@ref3]--[@ref5]). Therefore, authors should mention kind of beta-blocker therapy used in this study group.

In conclusion, ED is more common in men with IHD. Nebivolol, a third-generation beta-blocker, seems to have beneficial effects on ED compared with metoprolol ([@ref3]--[@ref5]). Kind of beta-blocker therapy might affect ED in patients with IHD.
